Fate Therapeutics
FATE
FATE
53 hedge funds and large institutions have $114M invested in Fate Therapeutics in 2017 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% more funds holding
Funds holding: 37 → 53 (+16)
7.26% less ownership
Funds ownership: 67.73% → 60.47% (-7.3%)
Holders
53
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$11.5M | |
| 2 | +$2.38M | |
| 3 | +$2.14M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.15M |
| 5 |
Millennium Management
New York
|
+$891K |
Top Sellers
| 1 | -$8.25M | |
| 2 | -$4.11M | |
| 3 | -$151K | |
| 4 |
PA
Parallel Advisors
San Francisco,
California
|
-$63K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$60.2K |